Advanced Search

Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2010 June;58(3) > Minerva Cardioangiologica 2010 June;58(3):343-55



A Journal on Heart and Vascular Diseases

Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752

Frequency: Bi-Monthly

ISSN 0026-4725

Online ISSN 1827-1618


Minerva Cardioangiologica 2010 June;58(3):343-55



Contrast echocardiography: mechanism of action, safety and clinical applications

Soliman O. I.I., De Jong N., Van Der Zwaan H. B., Galema T. W., Vletter W. B., Van Dalen B. M., Schinkel A. F.L., Ten Cate F. J., Geleijnse M. L.

Department of Cardiology, The Thoraxcenter, Biomedical Engineering, Erasmus MC, Rotterdam, The Netherlands

Since its initial description by Gramiak and Shah in 1968, contrast echocardiography has become an established practice world-wide. Microbubbles have the unique property of being pure intravascular tracers. The basic rationale behind bubble imaging is the characteristic responses to ultrasound power that results in enhanced ultrasound images from the blood pool. Therefore, whenever there is blood pool there is a potential application for contrast ultrasound. Clinical applications of contrast echocardiography have been vastly grown from diagnostic applications such as detection of a persistent foramen ovale to drug delivery. This article reviews the mechanism of action, safety and clinical applications of contrast echocardiography.

language: English


top of page